Jane Street Group, LLC Viking Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $16.9 Million - $23.9 Million	338,800 New	338,800 $21.4 Million
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $114,180 - $148,060	-22,000 Reduced 50.81%	21,300 $128,000
Q1 2021 May 18, 2021	BUY	$5.74 - $9.67 $152,110 - $256,255	26,500 Added 157.74%	43,300 $274,000
Q4 2020 Feb 17, 2021	BUY	$5.3 - $6.71 $3,180 - $4,026	600 Added 3.7%	16,800 $95,000
Q3 2020 Nov 17, 2020	SELL	$5.73 - $8.11 $7,449 - $10,543	-1,300 Reduced 7.43%	16,200 $94,000
Q2 2020 Aug 17, 2020	SELL	$4.35 - $8.08 $98,309 - $182,608	-22,600 Reduced 56.36%	17,500 $126,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $388,970 - $787,965	40,100 New	40,100 $699,000

476

63.4M

5.76M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.5B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.